You just read:

Final EPOS Study Results Published in Acta Neurologica Scandinavica Show Anti-epilepsy Treatment Zebinix® (Eslicarbazepine Acetate) Administered as Only Add-on to a Current Monotherapy Leads to High Retention and Seizure Freedom Rates and is Well-tolerated in Everyday Clinical Practice

News provided by

Eisai

29 Feb, 2016, 00:01 GMT